When was iFormulate founded?

iFormulate was founded in 2010.

Where is iFormulate located?

iFormulate is headquartered in Pleasanton, United States.

Is iFormulate a funded company?

iFormulate is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does iFormulate rank among its competitors?

iFormulate ranks 388th amongst 739 active competitors, of which 48 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of iFormulate?

iFormulate's top competitors include Abcam, Enzo and Meridian Bioscience. Among them, BioLamina secured the most recent funding round in April, 2026.

iFormulate - 2026 Company Profile & Competitors

Company Details

IFormulate is an AI-based provider of reagent for drug formulation development. The company uses a high throughput algorithm that utilizes the rational design of experiments and formulation parameters, to develop a pharmaceutically acceptable drug product. It offers reagents like RS-1, 2and 3 which helps in pH balance along with, ionic strength, buffer concentration, stabilizer concentration.

Website: www.iformulate.net/
Phone Number: +1 **********

Key Metrics

Founded Year

2010

Location

Pleasanton, United States

Stage

Unfunded

Ranked

388^th among 739 active competitors

Similar Companies

Abcam & 877 more

View iFormulate's full profile

iFormulate has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of iFormulate include Abcam, Enzo and Meridian Bioscience. Here is the list of Top 10 competitors of iFormulate, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	67/100
3rd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
4th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, BDC & 1 others	58/100
5th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
6th	Luminex 1995, Austin (United States), Acquired	Developer of instruments, reagents and kits for clinical diagnostics and life science research	-	Public Health Emergency, National Science Foundation ... & 1 others	55/100
7th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Telegraph Hill Partners, Europa	55/100
8th	PL BioScience 2015, Aachen (Germany), Series A	Manufacturer of human platelet lysate products for cell culture applications	$13M	TechVision Fonds, Brightlands Venture Partners ... & 18 others	54/100
9th	Huwel Life 2015, Hyderabad (India), Seed	Molecular diagnostic solutions and products for the healthcare industry	$106K	BIRAC, AIC-CCMB & 2 others	54/100
10th	Genetix Biotech 2001, Delhi (India), Unfunded	Provider of kits and reagents for life sciences companies	-	-	53/100
388th	iFormulate 2010, Pleasanton (United States), Unfunded	AI based provider of reagent for drug formulation development	-	-	24/100